A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia - NCT00977522-20036 (Clinical Trial 398231)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy398231.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Washington |
|
State:
|
|
DC |
| Zip Code: |
|
20036 |
| Conditions: |
|
Schizophrenia |
| Purpose: |
|
This study is examining the efficacy of PF-03463275 compared to placebo in treating negative
symptoms of schizophrenia when added to ongoing antipsychotic treatment in stable
outpatients with schizophrenia.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Subjects must have a current diagnosis of schizophrenia of paranoid (295.30),
disorganized (295.10), or undifferentiated (295.90) subtype in the residual phase.
- Subjects must be in ongoing maintenance antipsychotic monotherapy with risperidone,
olanzapine, quetiapine, ziprasidone, paliperidone, or aripiprazole. Subjects must be
on a stable medication treatment regimen for at least 2 months.
- Evidence of stable symptomatology at least 3 months.
Exclusion Criteria:
- Female subjects who are pregnant or breastfeeding.
- Subjects with evidence or history of a clinically significant medical condition which
would increase risk or which could interfere with the interpretation of trial
results.
- Subjects who have DSM IV defined psychoactive substance dependence (including alcohol
and excluding nicotine and caffeine dependence) within 12 months of screening or
substance abuse within 3 months prior to screening. |
|
|
|
| Study is available at: |
|
Pfizer Investigational Site
Washington, DC 20036
United States
Primary Contact:
Pfizer CT.gov Call Center
Phone: 1-800-718-1021 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|